EP3733712
Meðferðaráform og aðferðir til meðhöndlunar á heila- og mænusiggi með því að nota ófatúmúmab
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.8.2017EP published:
24.5.2023EP application number:
20180938.1
EP translation filed:
21.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
10.8.2037Expiry date:
10.8.2026Next due date:
31.8.2026
Title in English:
REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMABLanguage of the patent:
English
Timeline
Today
11.8.2017EP application
24.5.2023EP Publication
21.8.2023Translation submitted
15.9.2023Registration published
10.8.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
WALLSTRÖM, ErikAddress:
4002 Basel, CH
Name:
SAVELIEVA PRAZ, MarinaAddress:
4002 Basel, CH
Name:
KAKARIEKA WEISSKOPF, Algirdas JonasAddress:
4002 Basel, CH
Name:
KAHN, Joseph MichaelAddress:
East Hanover, NJ 07936-1080, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662374986 PDate:
15.8.2016Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 16.8.2023
Expires: 10.8.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 23.7.2024
Expires: 10.8.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 11.8.2025
Expires: 10.8.2026
Payer: Árnason Faktor ehf.